Work

Autologous Cell Therapy For HFrEF: Efficacy Outcomes At Two Years For The Roll-in Cohort Of A Phase III Pivotal Trial

Year: 2023

Type: article

Source: Journal of Cardiac Failure

DOI: 10.1016/j.cardfail.2022.10.264

Authors: Peter Johnston, Debby Holmes-Higgin, Amish Raval

Institutions: Johns Hopkins University, BioCardia (United States), University of Wisconsin–Madison, UW Health University Hospital

Language: English

Topic: Mesenchymal stem cell research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4365144351

FWCI: 0.173

Cites:

Cited by: 1

Related to: 10